Oncology Institute Q4 revenue up 41.6% to $142M, net loss narrows to $7.5M

Oncology Institute, Inc.

Q4 2025 revenue $142.0M (+41.6% YoY); gross profit $22.7M (+55.2%).
Net loss narrowed to $7.5M from $13.2M; adj EBITDA improved to $147K from -$7.8M.
FY2025 revenue $502.7M (+27.8%); net loss $60.6M vs $64.7M; adj EBITDA -$12.4M vs -$35.7M.
Added 9 new capitated contracts in CA, FL, NV covering ~260K lives; expanded Elevance, Humana, CarePlus partnerships.
Cash from operations positive $3.2M in Q4; cash balance $33.6M at year-end.

item 2.02 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001079973-26-000291
form_type: 8-K
ticker: TOI
cik: 0001799191
company_name: Oncology Institute, Inc.
filed_at: 2026-03-12T23:59:59+00:00
discovered_at: 2026-05-14T18:02:36.213258+00:00
generated_at: 2026-05-15T13:44:36.333723+00:00
sec_items: ["2.02", "9.01"]
event_type: earnings
sentiment: neutral
materiality_score: 0.7
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001079973-26-000291
json_url: https://secwatch.observer/filing/0001079973-26-000291.json
markdown_url: https://secwatch.observer/filing/0001079973-26-000291.md
text_url: https://secwatch.observer/filing/0001079973-26-000291.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1799191/000107997326000291/0001079973-26-000291-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1799191/000107997326000291/toi_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001079973-26-000291

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.